| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/29/2005 | CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/29/2005 | CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity |
| 06/29/2005 | CN1633417A Imidazolone derivatives for the treatment of viral diseases |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633415A Antibacterial mutilins |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 06/29/2005 | CN1633411A Compounds for modulating cell proliferation |
| 06/29/2005 | CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/29/2005 | CN1633309A Method of radio-labelling biomolecules |
| 06/29/2005 | CN1633308A Treatment of ophthalmic disorders using urea and urea derivatives |
| 06/29/2005 | CN1633307A Oral solid solution formulation of a poorly water-soluble active substance |
| 06/29/2005 | CN1633306A Viral inhibition by n-docosanol |
| 06/29/2005 | CN1633305A Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| 06/29/2005 | CN1633304A Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 06/29/2005 | CN1633302A Method for producing high-quality hydrophobic licorice extract |
| 06/29/2005 | CN1633300A Percutaneous preparations |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633298A Novel use of 2-phenyl-substituted imidazotriazinones |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633295A Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633293A 5-ht2b receptor antagonists |
| 06/29/2005 | CN1633292A Cotherapy with an oxazolidinone and a vitamin B |
| 06/29/2005 | CN1633291A 2-oxazolamines and their use as 5-ht2b receptor antagonists |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1633288A Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
| 06/29/2005 | CN1633287A Biphenil derivatives and their use as antiandrogenic agents |
| 06/29/2005 | CN1633286A Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 06/29/2005 | CN1633285A 组合物 The composition |
| 06/29/2005 | CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/29/2005 | CN1633283A Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| 06/29/2005 | CN1633281A Intraorally disintegrating valdecoxib compositions |
| 06/29/2005 | CN1633280A Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
| 06/29/2005 | CN1633245A Water-dispersible coenzyme q10 dry powders |
| 06/29/2005 | CN1633244A Aqueous chondro protective compositions having defined pH limitations for efficacious delivery |
| 06/29/2005 | CN1633243A Pet food composition for skin photoprotection |
| 06/29/2005 | CN1632119A Human LSB gene sequence, encoded polypeptide thereof, preparation method and use therefor |
| 06/29/2005 | CN1631902A Angelica polysaccharide and its preparation and use |
| 06/29/2005 | CN1631895A Preparation method of amygdalin and its application in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 06/29/2005 | CN1631866A Branched chain fatty acid for treating diabetes mellitus |
| 06/29/2005 | CN1631865A Compounds with anti neurocyte apoptosis function |
| 06/29/2005 | CN1631404A Medical application of rehmannia root extractive in resisting asthma and allergy |
| 06/29/2005 | CN1631376A Compound medicine compatibility method of ion pair agent and vanadium compound and the application thereof |
| 06/29/2005 | CN1631373A Enteric coated formulation of Coriolus Versicolor Polysaccharide and its preparation process |
| 06/29/2005 | CN1631372A Microbial drug material, its preparing method and usage |
| 06/29/2005 | CN1631371A Oral administered bitter free powder of macrolide antibiotic, its prescription and preparation process |
| 06/29/2005 | CN1631370A Pharmacetutical composition for treating cardiovascular and cerebrovascular disease and its preparing process |
| 06/29/2005 | CN1631369A Cream for treating skin disease |
| 06/29/2005 | CN1631368A Sustained release formulation containing effective active component of galanthamin and its preparation process |
| 06/29/2005 | CN1631367A Freeze dried powder injecta of doxofylline and its preparation |
| 06/29/2005 | CN1631366A Enteric coated sustained releasing tablet of gliclazide óÄ and its preparation process |
| 06/29/2005 | CN1631365A Sodium salinomycin powder and its preparation |
| 06/29/2005 | CN1631364A Application of tanshinone óÄA in pharmacy |
| 06/29/2005 | CN1631363A Preventives/remedies for arteriosclerosis |
| 06/29/2005 | CN1631362A Anti cancer sustained releasing composition and its preparation method |
| 06/29/2005 | CN1631361A Application of alpha cyclo-alanine in the process for preparing medicine to treat cerebrovascular and cardiovascular disease |
| 06/29/2005 | CN1631360A Freeze dried injection of lysine hydrochloride and its preparation process |
| 06/29/2005 | CN1631359A Compound calcium replenishing injection |
| 06/29/2005 | CN1631358A Compound pseudoephedrine hydrochloric acid containing powder for treating cold, its prescription and preparation method |
| 06/29/2005 | CN1631193A Instant balsam pear cold tea and its making method |
| 06/29/2005 | CN1208828C Erase method for non-volatile memory |
| 06/29/2005 | CN1208381C Rapidly decomposing chitosan-based pellets |
| 06/29/2005 | CN1208375C Powdered rubber powder containing modified filler, its preparing method and its use |
| 06/29/2005 | CN1208351C Nano crystal cellulose-heparin complex substance and preparing method thereof |
| 06/29/2005 | CN1208342C [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application |
| 06/29/2005 | CN1208341C S-substituted 11 & beta-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for production thereof and pharmaceutical preparations containing these compounds |
| 06/29/2005 | CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives |
| 06/29/2005 | CN1208335C Thiazolidinedione derivative and its use as antidiabetic |
| 06/29/2005 | CN1208333C Indole derivatives useful for the treatment of osteoporosis |
| 06/29/2005 | CN1208330C Method for extracting red-rooted salvia root anti-peptic ulcer effective part |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208323C Alpha-substituted carboxylic acid derivatives |
| 06/29/2005 | CN1208322C Dihydroindole and tetrahydroquinoline derivatives |
| 06/29/2005 | CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/29/2005 | CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/29/2005 | CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 06/29/2005 | CN1208095C Medical composite biological bone cement powder, bone cement liquid and composite biological bore cement |
| 06/29/2005 | CN1208093C Pharmaceutical composition and process thereof |
| 06/29/2005 | CN1208090C Pregelatinized starch in controlled release formulation |
| 06/29/2005 | CN1208080C Application of capsule of schisandra fruit for preparing medicine for treating sleep disorder |
| 06/29/2005 | CN1208074C Externally used Chinese medicinal preparation for treating gynaecology disease of cervicitis |
| 06/29/2005 | CN1208073C Ointment for treating various skin diseases and preparation method thereof |
| 06/29/2005 | CN1208069C Process for preparing liquid medicine to treat dermatopathy |
| 06/29/2005 | CN1208068C Externally used proprietary Chinese traditional medicine for treating yang deficiency and yin cold disease |
| 06/29/2005 | CN1208066C Use of cyclic ether for preparation of medicaments affecting glucose tolerance |
| 06/29/2005 | CN1208065C Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs |
| 06/29/2005 | CN1208064C Hyperhydrated citicoline, process and use |
| 06/29/2005 | CN1208063C Medicine composition for treating cold |
| 06/29/2005 | CN1208062C Sea urchin containing preparation and its preparing method |
| 06/29/2005 | CN1208061C Artesunate and dihydroarteannuin medicine preparation for proofing formation of blood vessel and use thereof |
| 06/29/2005 | CN1208060C Compound of ceferamet used for injection |
| 06/29/2005 | CN1208059C Medication comprising lornoxicam and niacinamide |
| 06/29/2005 | CN1208058C Oxazolidinone tablet formulation |
| 06/29/2005 | CN1208057C Compound Zedoary Turmeric oil preparation and process for making same |
| 06/29/2005 | CN1208056C Medicine containing Anemonin as effective component for treating aseptic inflammation |
| 06/29/2005 | CN1208055C Use of amino acids for making medicine for treating to insulin-resistance |